Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celso Arango

Showing results (351-360 of 504) with videos related to

Pageof 51
Sort By:
Translational Psychiatry|January 19, 2019
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort studyEmanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, et al.
European Child & Adolescent Psychiatry|November 4, 2020
Subgrouping children and adolescents with disruptive behaviors: symptom profiles and the role of callous-unemotional traitsMireia Rosa-Justicia, Melanie C Saam, Itziar Flamarique, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Sulcal Widening in Schizophrenia Maps onto Sulcal Hubs and Energy-Synaptic GenesJavier González-Peñas, Hugo G Schnack, Carmen Rueda Hernández, et al.
Translational Psychiatry|June 23, 2019
Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort studyEmanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, et al.
Research Square|January 9, 2026
Multicenter retrospective study on effectiveness, reported side effects, and cognitive outcomes of SSRIs in 22q11.2 deletion syndromeCaren Latrèche, Valentina Mancini, Marija Dvojakovska, et al.
Psychological Medicine|April 29, 2020
Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controlsMusa Sami, Diego Quattrone, Laura Ferraro, et al.
Eclinicalmedicine|June 30, 2021
Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysisGonzalo Salazar de Pablo, Filippo Besana, Vincenzo Arienti, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 31, 2021
Relationships between social withdrawal and facial emotion recognition in neuropsychiatric disordersAlejandro de la Torre-Luque, Alba Viera-Campos, Amy C Bilderbeck, et al.
Schizophrenia Research|March 3, 2024
A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohortMargot I E Slot, Hendrika H van Hell, Inge Winter-van Rossum, et al.
Schizophrenia Research|September 14, 2013
Issues and perspectives in designing clinical trials for negative symptoms in schizophreniaStephen R Marder, Larry Alphs, Ion-George Anghelescu, et al.
Pageof 51

Showing results (351-360 of 504) with videos related to

Sort By:
Pageof 51
Translational Psychiatry|January 19, 2019
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort studyEmanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, et al.
European Child & Adolescent Psychiatry|November 4, 2020
Subgrouping children and adolescents with disruptive behaviors: symptom profiles and the role of callous-unemotional traitsMireia Rosa-Justicia, Melanie C Saam, Itziar Flamarique, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Sulcal Widening in Schizophrenia Maps onto Sulcal Hubs and Energy-Synaptic GenesJavier González-Peñas, Hugo G Schnack, Carmen Rueda Hernández, et al.
Translational Psychiatry|June 23, 2019
Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort studyEmanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, et al.
Research Square|January 9, 2026
Multicenter retrospective study on effectiveness, reported side effects, and cognitive outcomes of SSRIs in 22q11.2 deletion syndromeCaren Latrèche, Valentina Mancini, Marija Dvojakovska, et al.
Psychological Medicine|April 29, 2020
Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controlsMusa Sami, Diego Quattrone, Laura Ferraro, et al.
Eclinicalmedicine|June 30, 2021
Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysisGonzalo Salazar de Pablo, Filippo Besana, Vincenzo Arienti, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 31, 2021
Relationships between social withdrawal and facial emotion recognition in neuropsychiatric disordersAlejandro de la Torre-Luque, Alba Viera-Campos, Amy C Bilderbeck, et al.
Schizophrenia Research|March 3, 2024
A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohortMargot I E Slot, Hendrika H van Hell, Inge Winter-van Rossum, et al.
Schizophrenia Research|September 14, 2013
Issues and perspectives in designing clinical trials for negative symptoms in schizophreniaStephen R Marder, Larry Alphs, Ion-George Anghelescu, et al.
Pageof 51